Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewGilteritinib is a potent Fms-like tyrosine kinase 3 (FLT3) and AXL inhibitor (IC50 = 0.29 nM and 0.73 nM, for FLT3 and AXL, respectively). In vivo, Gilteritinib reduces tumor growth and improves survival in xenograft and intra-bone marrow transplantation models of FLT3 mutated acute myeloid leukemia. Gilteritinib is orally bioavailable.
M. Wt | 552.71 |
Formula | C29H44N8O3 |
Storage | Store at -20°C |
Purity | ≥98% (HPLC) |
CAS Number | 1254053-43-4 |
InChI Key | GYQYAJJFPNQOOW-UHFFFAOYSA-N |
Smiles | O=C(N)C=1N=C(C(=NC1NC2=CC=C(C(OC)=C2)N3CCC(N4CCN(C)CC4)CC3)NC5CCOCC5)CC |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Solvent | Max Conc. mg/mL | Max Conc. mM | |
---|---|---|---|
Solubility | |||
DMSO | 5.53 | 10 |
The following data is based on the product molecular weight 552.71. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 18.09 mL | 90.46 mL | 180.93 mL |
0.5 mM | 3.62 mL | 18.09 mL | 36.19 mL |
1 mM | 1.81 mL | 9.05 mL | 18.09 mL |
5 mM | 0.36 mL | 1.81 mL | 3.62 mL |
References are publications that support the biological activity of the product.
Mori et al (2017) Gilteritinib, a FLT3/AXL inhibitor, shows antileukemic activity in mouse models of FLT3 mutated acute myeloid leukemia. Invest.New Drugs 35 556 PMID: 28516360
If you know of a relevant reference for Gilteritinib, please let us know.
Keywords: Gilteritinib, Gilteritinib supplier, FLT3, AXL, inhibitors, inhibits, FMS-like, receptor, tyrosine, kinase-3, acute, myeloid, leukemia, xenograft, AML, orally, bioavailable, , in, vivo, 7891, Tocris Bioscience
Citations are publications that use Tocris products.
Currently there are no citations for Gilteritinib. Do you know of a great paper that uses Gilteritinib from Tocris? Please let us know.
There are currently no reviews for this product. Be the first to review Gilteritinib and earn rewards!
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image